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Abstract Lysophosphatidic acid (LPA) exerts multiple biolog-
ical functions through G protein-coupled receptors (EDG2/
LPA1, EDG4/LPA2, and EDG7/LPA3) and is present in serum
where it is associated with albumin. In this study we examined
LPA activity in various biological £uids by measuring the LPA-
induced increase in the intracellular concentration of calcium ion
in three types of Sf9 insect cells, each expressing one of the
LPA receptors. Using this system, we found that EDG2 and
EDG4, but not EDG7, were activated strongly by addition of
incubated plasma. By contrast, LPA detected in seminal plas-
ma, which contains a low concentration of albumin, selectively
activated EDG7. After LPA in these samples was extracted and
reconstituted, it activated all three receptors. We also found
that serum albumin readily inhibits the activation of EDG7
but not the activation of EDG2 or EDG4. In addition, plasma
from Nagase analbuminemic rats but not plasma from control
Sprague^Dawley rats was found to strongly activate EDG7,
although the plasma of these two types of rats contained equal
amounts of LPA and activated both EDG2 and EDG4. The
present study shows that serum albumin can negatively regulate
EDG7 but not EDG2 or EDG4, and suggests that protein fac-
tors are present in seminal plasma and deliver LPA e⁄ciently to
EDG7 but not to EDG2 or EDG4. 4 2002 Published by El-
sevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Lysophosphatidic acid (1- or 2-acyl-lysophosphatidic acid;
LPA) is a lipid that mediates multiple cellular processes [1^3],
including platelet aggregation, smooth muscle contraction,
cell proliferation, and cytoskeletal reorganization (e.g. gener-
ation of actin stress ¢bers and inhibition of neurite out-
growth). LPA evokes its multiple e¡ects through G protein-
coupled receptors (GPCR) that are speci¢c to LPA. Recent
studies have identi¢ed a new family of receptor genes for LPA
(reviewed in [4,5]). Members of this family include three
GPCRs belonging to the EDG (endothelial cell di¡erentiation
gene) family, EDG2/LPA1 [6], EDG4/LPA2 [7], and EDG7/
LPA3 [8,9]. They appear to have distinct tissue distribution
patterns [5^8], indicating speci¢c functions for each receptor.
Indeed, it was recently shown by targeted deletion that the
EDG2 receptor is required for normal development of inborn
and neonatal behavior [10].
LPA has been detected in various biological £uids such as
serum [11], and ascitic £uid from ovarian cancer patients [12].
It is also found to a lesser extent in plasma. LPA is also
produced by activated platelets [13]. Recent studies on the
mechanisms of LPA production have identi¢ed several syn-
thetic pathways and identi¢ed several phospholipases involved
in these pathways [13^15], which may explain why such a
variety of LPA species are detected in vivo. Interestingly,
each LPA receptor is activated di¡erentially by di¡erent
LPA species [16], indicating a possible link between each syn-
thetic pathway and each receptor.
In biological £uids, LPA appears to be associated with
protein factors. Albumin is an abundant, lipid-binding protein
in blood plasma [17], where it occurs at a concentration of
around 4 g/dl. The primary role of albumin is to transport
fatty acids, but its versatile binding capacity implies additional
functions such as transport of drugs and especially, lysophos-
pholipid mediators, including sphingosine 1-phosphate, plate-
let-activating factor, lysophosphatidylcholine, and LPA. In-
deed, it has been demonstrated that serum albumin and
other LPA-binding proteins modify the cellular function of
LPA [11,18]. This notion strongly indicates that when LPA
is detected in biological £uids by lipid analysis using classical
methods such as thin-layer chromatography or recently devel-
oped mass spectrometry, its presence and activity should also
be evaluated in the light of receptor activation. Most mam-
malian culture cells express one or more LPA receptors [19].
In addition, they also express other receptors for growth fac-
tors. Thus, it is di⁄cult to evaluate the presence of LPA in
biological £uids such as serum and plasma through activation
of LPA receptors, because these biological £uids contain other
growth factors that evoke multiple cell responses in the cells.
We recently established a bioassay system to evaluate the
activation of each of the LPA receptors, individually ex-
pressed in Sf9 insect cells by measuring the change in intra-
cellular calcium concentration evoked by the addition of LPA
[8,16]. In the absence of LPA receptor expression, these insect
cells did not show any calcium response to any of the biolog-
ical £uids, which enabled us to measure LPA activity in the
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biological £uids. In this study, to understand where and how
LPA is produced and how it acts on cellular receptors, we
measured LPA activity in various biological £uids by evaluat-
ing receptor activation using the bioassay system. We demon-
strate here that two biological £uids, blood plasma and semi-
nal plasma, di¡erentially activate LPA receptors.
2. Materials and methods
2.1. Materials
Bovine serum albumin (BSA; fatty acid-free; A-6003) was pur-
chased from Sigma. 1-Oleoyl-LPA (18:1) and 1-[3H]oleoyl-LPA
(18:1) were purchased from Avanti Polar Lipids (Alabaster, AL,
USA) and Amersham Pharmacia Biotech (Buckinghamshire, Eng-
land), respectively. Other chemicals were purchased from Wako
Pure Chemical Industries (Osaka, Japan). HPPA (3-(4-hydroxyphen-
yl) propionic acid) was from Nacalai (Kyoto, Japan).
2.2. Animals
Male Nagase analbuminemic rats (NAR) (8 weeks old) and male
Sprague^Dawley rats (SDR) of similar age were purchased from Ja-
pan SLC (Shizuoka, Japan). The rats were fed a standard rat chow ad
libitum until the time of the study. Albumin in plasma from NAR and
SDR was determined using a bromocresol purple dye binding kit from
Ono Pharmaceutical (Osaka, Japan).
2.3. Evaluation of LPA receptor activation
LPA receptor activation of biological samples was evaluated by the
Ca2þ assay using Sf9 cells expressing each LPA receptor as described
previously [8,16]. Brie£y, agonist-induced Fura-2 AM £uorescence of
Fura-2-loaded Sf9 cells expressing the EDG2^4 chimeric receptor,
EDG4, or EDG7 in quartz cuvettes was monitored at excitation
wavelengths of 340 and 380 nm and an emission wavelength of 500
nm using a CAF-110 spectro£uorometer (Japan Spectroscopy, Tokyo,
Japan). As described previously [8], EDG2 expressed in insect Sf9 cells
could not mediate Ca2þ signaling induced by LPA. We therefore
constructed the EDG2^4 chimeric receptor, in which the intracellular
Fig. 1. Di¡erential activation of LPA receptors by incubated blood plasma and seminal plasma. Incubated blood plasma prepared from SDR
(A) or freshly prepared seminal plasma from healthy volunteers (B) was added to Fura-2-loaded Sf9 cells expressing human EDG2, EDG4, or
EDG7. LPA activities were evaluated by measuring increases in [Ca2þ]i in the insect cells after samples were added to the cells. Arrows indicate
the application of the diluted samples (100-fold dilution for LPA extracted from the incubated plasma and 10-fold dilution for LPA extracted
from the seminal £uids). Dose^response curves are shown in the lower panels.
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C-terminal amino acids of EDG2 (41 amino acids) were replaced with
those of EDG4 (54 amino acids), and found that the chimeric receptor
did transduce the LPA-induced Ca2þ response in the insect cells [16].
In this study, we used this chimeric receptor as EDG2.
2.4. Quanti¢cation of LPA
LPA concentration was determined by £uorometry of H2O2 using
HPPA (7.5 mM) as a peroxidase donor [20] generated by reaction of
LPA samples with 500 U/ml monoglyceride lipase (Asahi Chemical
Industry, Shizuoka, Japan) and 500 U/ml glycero-3-phosphate oxidase
(Asahi Chemical Industry) in a bu¡er containing 50 mM HEPES,
2 mM CaCl2, 0.2% Triton X-100, 100 U/ml peroxidase (Toyobo,
Tokyo, Japan), pH 7.5 in a total volume of 1500 Wl. Fluorescence
intensity at excitation at 320 nm/emission at 404 nm was measured
with a £uorometer (Hitachi, Ibaraki) 5 min after mixing the samples.
We detected LPA at concentrations as low as 0.1 nmol and obtained
linearity up to 10 nmol of LPA in this system. To determine low
concentrations of LPA, LPA in a sample was extracted by the method
of Bligh and Dyer [21] under acidic conditions (pH 3.0, see below) and
more samples were introduced in the assay.
2.5. Preparation of biological £uids
The biological £uids used in this study included three types of blood
£uid from rats and six other types of £uid from human volunteers.
Rat blood was collected by cardiac puncture. Rat serum was prepared
by allowing the blood to clot for 60 min at 37‡C and then centrifuging
it at 2000Ug for 20 min at 4‡C to remove the clot. To obtain plasma,
blood was drawn in the presence of one-sixth volume of acid citrate
dextrose (3% citrate, 2.2% D-glucose, pH 6.0) and immediately centri-
fuged at 2000Ug for 20 min at 4‡C to remove the cells. The third
blood £uid used in the assays was incubated plasma, which was ob-
tained by incubating plasma at 37‡C for 60 min. The human £uids
were collected from healthy men between the ages of 22 and 26. Semi-
nal £uids (n=4) were kept at room temperature for 30 min after
collection and then mixed with an equal volume of phosphate-bu¡-
ered saline. Seminal plasma was prepared by centrifuging the seminal
Fig. 2. LPA in biological £uids restores activities after extraction by organic solvents. Lipid extracts from incubated blood plasma of SDR (A)
or seminal plasma (B) were reconstituted in bu¡er containing 0.1% BSA and added to Fura-2-loaded Sf9 cells expressing human EDG2,
EDG4, or EDG7. LPA activities were evaluated by increases in [Ca2þ]i in the insect cells after samples were added to the cells. Arrows indicate
the application of the diluted samples (100-fold dilution for the incubated plasma and 10-fold dilution for the seminal £uids). Dose^response
curves are shown in the lower panels.
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£uid at 500Ug for 10 min at room temperature to remove the sperm.
LPA in the seminal plasma was extracted by the method of Bligh and
Dyer [21] under acidic conditions (pH 3.0). The other human biolog-
ical £uids were saliva, urine, tears, sweat, and nasal mucus (n=3), and
were used immediately after collection.
2.6. Lipid extraction
Phospholipids were extracted by the method of Bligh and Dyer [21]
under acidic conditions by adjusting the pH to 3.0 with 1 N HCl.
Lipids in the aqueous phase were re-extracted and pooled with the
previous organic phase. The extracted lipids were dried, dissolved
in chloroform/methanol (1:1) and used for the bioassays. The recov-
ery of lipids was monitored by the addition of trace amounts of
1-[3H]oleoyl-LPA to the samples. Under the above conditions, recov-
ery of 1-[3H]oleoyl-LPA was always s 95%.
3. Results and discussion
3.1. Detection of LPA in biological £uids by evaluating the
activation of LPA receptors
We searched for LPA activity in various biological £uids by
measuring the LPA-induced change in intracellular calcium
concentration ([Ca2þ]i) in three types of Sf9 insect cells,
each expressing one of the LPA receptors (EDG2, EDG4,
and EDG7). We previously showed that each LPA receptor
expressed in the Sf9 cells was strongly activated by exoge-
nously added sub-nanomolar to nanomolar concentrations
of LPA [8,16]. In addition, the [Ca2þ]i of intact Sf9 cells or
cells infected with wild-type baculovirus was not a¡ected by
addition of various biological £uids (data not shown), which
enabled us to measure LPA activity in the biological £uids
with high sensitivity. To evaluate the activation of LPA re-
ceptors, we expressed each recombinant receptor in Sf9 cells
using a baculovirus system and measured the increases in the
[Ca2þ]i evoked by addition of biological £uids or LPA.
Among the biological £uids tested (serum, plasma, incubated
plasma, saliva, urine, tears, sweat, nasal mucus, and seminal
plasma), serum and incubated plasma contain LPA abun-
dantly [11,22]. Consistent with this, addition of incubated
blood plasma (Fig. 1A, upper panel) induced a rapid in-
crease in the [Ca2þ]i in Sf9 cells expressing EDG2 and
EDG4. However, the increase in the [Ca2þ]i was not observed
at all in Sf9 cells expressing EDG7. Similar results were
obtained when serum was added to the cells (data not shown).
In contrast, seminal plasma induced an EDG7-speci¢c re-
sponse (Fig. 1B, upper panel). The dose dependences of
both blood and seminal plasma (Fig. 1A,B, lower panels)
con¢rmed that the two biological £uids di¡erentially activate
LPA receptors.
3.2. Extracted LPA activates all LPA receptors
The preceding results show that di¡erent biological £uids
activate di¡erent receptors. One explanation for this is that
di¡erent biological £uids have di¡erent types of LPAs, be-
cause LPAs with di¡erent acyl chains and acyl positions
have been shown to di¡erentially activate the LPA receptors
[8,16]. Another possibility is that the biological £uids have one
or more water-soluble components that associate with the
LPA and in£uence its activity. To test these possibilities we
extracted LPA with organic solvents and dissolved it in bu¡er
containing 0.1% BSA, and used it in the Ca2þ assay. As
shown in Fig. 2, LPA from both blood (Fig. 2A) and seminal
plasma (Fig. 2B) activated all LPA receptors. These results
support the latter possibility, i.e. that the di¡erential activa-
tion of the receptors is due to one or more water-soluble
components in the biological £uids.
3.3. E¡ect of serum albumin on the activation of LPA receptors
LPA in serum is almost exclusively associated with serum
albumin [11]. In the course of this study we found that the
albumin concentration in the bu¡er used in the Ca2þ assay is
critical for the activation of LPA receptors. As shown in Fig.
3, high concentrations of BSA (s 5%, w/w) completely inhib-
ited activation of the three LPA receptors induced by 100 nM
LPA. Among the three receptors, EDG7 was most sensitive to
the albumin concentration. 0.01% BSA inhibited EDG7 acti-
vation and 1% BSA completely blocked it. However, BSA
concentrations of 0.01% and 1% had no e¡ect on EDG2 or
EDG4 (Fig. 3).
To further evaluate the role of albumin in LPA receptor
activation, we utilized the NAR, a mutant strain in which
normal splicing of albumin mRNA does not occur. While
the plasma albumin concentration is 19.4 mg/ml in normal
SDR, it is only 0.4 mg/ml in NAR. The LPA levels in incu-
bated plasma from these two rat strains were comparable,
being 10.3S 2.1 WM (n=5) in NAR and 8.9S 2.3 WM (n=5)
in SDR. Consistent with this, we did not observe any di¡er-
ence in activation of EDG2 and EDG4 in the two rat strains
(Figs. 1A and 4A). In contrast, in the activation of EDG7, we
found that plasma from NAR induced a signi¢cant Ca2þ re-
sponse (Fig. 4A), whereas plasma from control animals (SDR)
induced a poor response (Fig. 1A).
The weak e¡ect of SDR plasma on EDG7 activation may
be due to the composition of the LPA species, as discussed
Fig. 3. Serum albumin di¡erentially modi¢es the activity of LPA to-
ward di¡erent LPA receptors. The e¡ect of albumin on the activation
of LPA receptors induced by 1-oleoyl-LPA (100 nM) was examined
by measuring the transient increase in [Ca2þ]i in Fura-2-loaded Sf9
cells expressing human EDG2, EDG4, or EDG7. Closed triangles,
squares and circles represent activation of EDG2, EDG4 and
EDG7, respectively. Activations are expressed relative to the activa-
tion of each receptor when the albumin concentration is 0%.
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above. To test this possibility we examined the activity of the
extracted LPA. After extraction, the lipid fractions from NAR
(Fig. 4B) and SDR (Fig. 2B) showed almost equal abilities to
activate EDG7, EDG2, and EDG4. Furthermore, addition of
BSA to NAR plasma weakened the activation of EDG7 (data
not shown). Thus, it can be concluded that the disappearance
of the major serum protein (albumin) but not the composition
of the acyl chain of LPA is responsible for the enhanced
reactivity of EDG7 to NAR plasma.
It is generally believed that serum albumin has some phys-
iological role in regulating the activities of lysophospholipid
mediators including platelet-activating factor, sphingosine
1-phosphate, lysophosphatidylcholine, and LPA, because the
biological activities of these compounds are dependent on
albumin concentration. Actually, LPA, which is present at
micromolar concentrations in serum, forms a complex with
albumin [11,23]. In this study we clearly demonstrated that
the albumin concentration is critical for the activation of
LPA receptors in a receptor type-speci¢c manner. We ob-
served that (1) higher concentrations of albumin (1^5%) sup-
pressed the activation of EDG7, but not the activation of
EDG2 or EDG4 (Fig. 3) and (2) plasma from NAR but not
from control SDR activated EDG7 (Fig. 4). Together, these
results clearly show that activation of EDG7 does not occur
in the presence of physiological concentrations of albumin,
since the albumin concentration in blood plasma is normally
about 4% (w/v). Furthermore, we detected LPA activity in
seminal plasma and found that EDG7 was selectively acti-
vated by the LPA (Fig. 1). The seminal plasma could not
activate either EDG2 or EDG4. However, when the LPA
was extracted from the seminal plasma with an organic sol-
vent and reconstituted in bu¡er containing albumin, its activ-
ity toward EDG2 and EDG4 was recovered. This strongly
indicates that seminal plasma has one or more carrier proteins
Fig. 4. Enhanced activation of EDG7 by blood plasma from NAR. Incubated blood plasma prepared from NAR (A) or lipids extracted from
the plasma (B) were added to Fura-2-loaded Sf9 cells expressing human EDG2, EDG4, or EDG7. LPA activities were evaluated by increases
in [Ca2þ]i in insect cells after samples were added to the cells. Arrows indicate the application of 100-fold diluted samples. Dose^response
curves are shown in the lower panels.
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that e⁄ciently deliver LPA to EDG7 but not to the other two
receptors. The carrier proteins are di¡erent from albumin,
because the e¡ect of LPA bound to albumin on activating
LPA receptors was opposite to the e¡ect to the LPA detected
in seminal plasma. The albumin concentration in seminal
plasma is very low (0.063%, w/v) [24]. This concentration
does not inhibit the activation of EDG7 (Fig. 3), which is
consistent with the selective activation of EDG7 by seminal
£uid. In addition to serum albumin, several cellular proteins,
such as fatty acid-binding protein [25] and an actin-severing
protein, gelsolin, have been characterized as LPA-binding
proteins. Like albumin, gelsolin is also present in plasma
(V100 Wg/ml). Recently it was demonstrated that gelsolin
enhances the e¡ects of LPA on cellular functions in rat car-
diac myocytes by binding to LPA [18]. If seminal plasma does
have a protein factor, it may di¡er from gelsolin, because
cardiac myocytes express both EDG2 and EDG4 [18], which
are not activated by LPA in seminal plasma (Fig. 1). EDG2
and EDG4 are widely distributed in both human and mouse
tissues, whereas EDG7 is distributed predominantly in repro-
ductive tissues such as testis, prostate, and ovary [8,9]. In
addition, EDG7 appears to be expressed by epithelial cells
in human prostate (our unpublished result). These cells are
exposed to seminal plasma but not to blood plasma. The
expression pattern of EDG7 also supports the hypothesis
that EDG7 has a role in reproductive tissues where the albu-
min concentration is low.
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